Nebzmart Gf 1Ml Combipack 5 Smartules

NEBZMART GF 1ML COMBIPACK 5 SMARTULES may interact with other medicines, such as:

• Antihypertensive medicines (e.g., propranolol, atenolol): Beta-blockers may reduce the bronchodilator effect of arformoterol and can worsen breathing symptoms. Avoid combination unless advised by your doctor.
• Antidiabetic medicines (e.g., insulin): Arformoterol may increase blood glucose levels, which can reduce the effectiveness of antidiabetic medicines. Regular blood sugar monitoring is recommended.
• Antiepileptic medicines (e.g., phenytoin): These medicines may alter the metabolism of arformoterol, potentially reducing its effectiveness. Your doctor may monitor your response to treatment.
• Other bronchodilators or sympathomimetic medicines (e.g., salbutamol): Concurrent use may increase the risk of side effects such as tremors, palpitations, and increased heart rate. Use with caution under medical supervision.
• Anticholinergic medicines (e.g., tiotropium): Combined use with glycopyrrolate may increase the risk of anticholinergic side effects such as dry mouth, constipation, blurred vision, and urinary retention.
• Medicines affecting heart rhythm (e.g., amitriptyline, quinidine): Concomitant use may increase the risk of QT prolongation and irregular heartbeat. Monitoring may be required.

Use NEBZMART GF 1ML COMBIPACK 5 SMARTULES with caution if you have:

• Heart disease (e.g., arrhythmia, ischemic heart disease): Arformoterol may increase heart rate and can trigger palpitations or irregular heartbeat. Your doctor may monitor your heart condition during treatment.
• Hypertension (high blood pressure): This medicine may cause mild increases in blood pressure in some patients. Regular monitoring may be required, especially if you already have uncontrolled hypertension.
• Glaucoma (especially narrow-angle glaucoma): Glycopyrrolate may increase intraocular pressure and worsen symptoms such as eye pain or blurred vision. Avoid contact of the nebulised mist with the eyes.
• Urinary retention or prostate enlargement (e.g., benign prostatic hyperplasia): Glycopyrrolate may reduce bladder emptying and worsen difficulty in passing urine. Inform your doctor if you experience urinary discomfort.
• Thyroid disorders (e.g., hyperthyroidism): Arformoterol may worsen symptoms such as increased heart rate or nervousness. Monitoring may be required during treatment.
• Seizure disorders (epilepsy): Beta2-agonists may lower the seizure threshold in some patients. Use with caution and inform your doctor if you have a history of seizures.

The frequency and duration of treatment with NEBZMART GF 1ML COMBIPACK 5 SMARTULES are decided by your doctor based on your condition. Use this medicine regularly as prescribed and do not change the schedule without consulting your doctor.

Using more respules than prescribed or taking doses too close together may increase the risk of side effects such as palpitations, tremors, dizziness, dry mouth, or difficulty in passing urine. If you experience any unusual symptoms, seek medical advice immediately.

If you miss a nebulisation session, take it as soon as you remember. If it is close to your next scheduled session, skip the missed one and continue your regular schedule. Do not use extra respules to make up for a missed session.